The University of Aberdeen has secured over £1 million in funding from the British Heart Foundation to further develop Trodusquemine, a promising drug that has shown potential in reducing fat in arteries and lowering "bad cholesterol," with hopes of advancing to human clinical trials to aid those suffering from severe atherosclerosis. #HeartDisease #MedicalResearch #CholesterolTreatment #GB #DK #FR #NL
Aberdeen researchers receive £1.1m to develop heart disease drug
